The Kirby Institute at UNSW Sydney is part of a consortium to receive funding and will lead program implementation in the Indo-Pacific.
This is expected to be the smallest Omicron wave so far. But eligible older and vulnerable people are still recommended to have a booster.
Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
The Kirby Institute has developed the first non-English version of its AI-driven epidemic warning tool EPIWATCH, expanding its availability in one of the world's most populous countries.
The World Health Organization has classified the EG.5 family of Omicron variants, including Eris, as ‘variants of interest’. What does that mean? And how does Eris differ to other Omicron variants?
If proven effective in future clinical trials, these therapeutics will be a key tool in the fight against COVID-19.
Project goals include improving long-term health for people living with HIV, fighting kidney disease and lessening the negative effects of chemotherapy in cancer patients.
UNSW researchers have been named as finalists in Australia’s most high-profile science awards.
Increasing treatment access and reducing undiagnosed infections is vital for combating HIV, UNSW researchers have shown.
There aren’t enough interventions for people who use drugs, new research shows.